CoChat

Type 2 diabetes: principles of pathogenesis and therapy

Open access
Stumvoll, Michael, Goldstein, Barry J, van Haeften, Timon W · 2005 · The Lancet

The DOI matches its Crossref record; 165 of the 172 references it cites were found in a registry or an index.

Abstract

Type 2 diabetes mellitus has become an epidemic, and virtually no physician is without patients who have the disease. Whereas insulin insensitivity is an early phenomenon partly related to obesity, pancreas beta-cell function declines gradually over time already before the onset of clinical hyperglycaemia. Several mechanisms have been proposed, including increased non-esterified fatty acids, inflammatory cytokines, adipokines, and mitochondrial dysfunction for insulin resistance, and glucotoxicity, lipotoxicity, and amyloid formation for beta-cell dysfunction. Moreover, the disease has a strong genetic component, but only a handful of genes have been identified so far: genes for calpain 10, potassium inward-rectifier 6.2, peroxisome proliferator-activated receptor gamma, insulin receptor substrate-1, and others. Management includes not only diet and exercise, but also combinations of anti-hyperglycaemic drug treatment with lipid-lowering, antihypertensive, and anti platelet therapy.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(05)61032-x

Cites

165 of 165 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 165 references

Research works printed but not linked: 2

  1. Kido, 2001, Clinical review 125: The insulin receptor and its cellular targets, J Clin Endocrinol Metab, 86, 972
  2. Yki-Järvinen, 1992, Glucose toxicity, Endocr Rev, 13, 415

Cited by

See all 2,662

Metadata

Authors
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W.
Affiliations
Thomas Jefferson University (US)
Venue
The Lancet
Publisher
Elsevier BV
Published
2005-04
Volume
365
Issue
9467
Pages
1333-1346
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2114041992
Cited by
2,662
References
172
Citations by year
2026: 67 · 2025: 113 · 2024: 146 · 2023: 142 · 2022: 165 · 2021: 139 · 2020: 141 · 2019: 110 · 2018: 140 · 2017: 128 · 2016: 121 · 2015: 147 · 2014: 142 · 2013: 156 · 2012: 164
FWCI
9.82
Type
journal article
Language
en
Open access
Licence
  • other-oa
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
Funders
  • U.S. Public Health Service (R01-063018, R01-43396)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK UO1-048468)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
type 2 diabetes, pathogenesis, insulin resistance, beta-cell dysfunction, insulin insensitivity, obesity, free fatty acids, inflammatory cytokines, adipokines, mitochondrial dysfunction, glucotoxicity, lipotoxicity, amyloid fibril formation, genetic susceptibility, CAPN10, Kir6.2, PPARγ, IRS-1, lipid-lowering therapy, antihypertensive therapy, antiplatelet therapy, diet and exercise
MeSH terms
Animals, Diabetes Mellitus, Type 2, Humans, Hyperglycemia, Insulin Resistance, Islets of Langerhans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Type 2 diabetes: principles of pathogenesis and therapy. https://app.cochat.ai/papers/10.1016/s0140-6736(05)61032-x
The paper
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005). Type 2 diabetes: principles of pathogenesis and therapy. The Lancet. https://doi.org/10.1016/s0140-6736(05)61032-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.